会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • NOVEL FIVE-MEMBERED RING COMPOUND
    • 新五元环化合物
    • US20110034466A1
    • 2011-02-10
    • US12989516
    • 2009-04-23
    • Hitoshi FujitaToshio KanaiSatoki Imai
    • Hitoshi FujitaToshio KanaiSatoki Imai
    • A61K31/5377C07D413/10A61P29/00
    • C07D277/20C07D277/42C07D417/10
    • Disclosed is a five-membered ring compound represented by formula (1) or a pharmaceutically acceptable salt thereof. The compound inhibits infiltration of leukocytes including eosinophils and lymphocytes, and is effective as a drug for treating various inflammations. The compound is highly safe and can be administered for a long period. A pharmaceutical product containing the five-membered ring compound or a pharmaceutically acceptable salt thereof is also disclosed. (In the formula, R1 represents a halogen atom or a phenyl group which may be substituted by a C1-C3 alkyl group or a C1-C3 alkoxy group; R2 represents a C1-C3 alkylene group which may be substituted by a C1-C3 alkyl group or a carbonyl group; R3 represents a C1-C3 alkyl group; R4 and R5 independently represent a hydrogen atom or a C1-C3 alkyl group, or —N(R4)R5 may represent a morpholino group which may be substituted by a C1-C3 alkyl group; Y2 represents a C2-C4 alkylene group; and R6 represents a hydrogen atom, a halogen atom, a C1-C3 alkyl group or a C1-C3 alkoxy group.)
    • 公开了由式(1)表示的五元环化合物或其药学上可接受的盐。 该化合物抑制嗜酸性粒细胞和淋巴细胞等白细胞的浸润,作为治疗各种炎症的药物是有效的。 该化合物是高度安全的,可以长期施用。 还公开了含有五元环化合物或其药学上可接受的盐的药物。 (式中,R1表示卤原子或可被C1-C3烷基或C1-C3烷氧基取代的苯基; R2表示可被C1-C3取代的C1-C3亚烷基 烷基或羰基; R3表示C1-C3烷基; R4和R5独立地表示氢原子或C1-C3烷基,或-N(R4)R5可以表示可以被 C1-C3烷基; Y2表示C2-C4亚烷基; R6表示氢原子,卤素原子,C1-C3烷基或C1-C3烷氧基)。
    • 2. 发明授权
    • Therapeutic agent for chronic obstructive pulmonary disease
    • 慢性阻塞性肺疾病治疗剂
    • US08012971B2
    • 2011-09-06
    • US11919135
    • 2006-04-28
    • Toshinari SugasawaTakashi NakajimaHitoshi FujitaToshio Kanai
    • Toshinari SugasawaTakashi NakajimaHitoshi FujitaToshio Kanai
    • A61K31/426A61K31/5377C07D417/10C07D277/38
    • A61K31/56A61K9/10A61K31/5377C07D277/42
    • Disclosed is a method for the prevention and/or treatment of a chronic obstructive pulmonary disease by administrating a 5-membered cyclic compound represented by the formula below: or a pharmaceutically acceptable salt of the compound or a prodrug of the compound or salt: wherein X represents an oxygen or sulfur atom; R1 represents a hydrogen atom, a substituted or unsubstituted alkyl or the like; R2 represents a hydrogen atom, a substituted or unsubstituted alkyl or the like; Y1 represents single bond, a substituted or unsubstituted alkylene or the like; the wavy line means an (E) or (Z) coordination; R3 represents a hydrogen atom, a substituted or unsubstituted aryl or the like; Y2 represents a substituted or unsubstituted alkylene or an alkenylene; R4 represents a hydrogen atom, a substituted or unsubstituted alkanoyl or the like; and R5 represents a hydrogen atom or a substituted or unsubstituted alkyl.
    • 本发明公开了一种预防和/或治疗慢性阻塞性肺疾病的方法,该方法是通过给予由下式表示的5元环状化合物:或化合物的药学上可接受的盐或其化合物或盐的前体药物:其中X 表示氧或硫原子; R1表示氢原子,取代或未取代的烷基等; R 2表示氢原子,取代或未取代的烷基等; Y1表示单键,取代或未取代的亚烷基等; 波浪线表示(E)或(Z)配位; R3表示氢原子,取代或未取代的芳基等; Y2表示取代或未取代的亚烷基或亚烯基; R4表示氢原子,取代或未取代的烷酰基等; 并且R 5表示氢原子或取代或未取代的烷基。
    • 4. 发明申请
    • THERAPEUTIC AGENT FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    • 慢性阻塞性肺疾病治疗药物
    • US20110263550A1
    • 2011-10-27
    • US13084503
    • 2011-04-11
    • Toshinari SugasawaTakashi NakajimaHitoshi FujitaToshio Kanai
    • Toshinari SugasawaTakashi NakajimaHitoshi FujitaToshio Kanai
    • A61K31/56A61P11/00A61K31/5377
    • A61K31/56A61K9/10A61K31/5377C07D277/42
    • Disclosed is a method for the prevention and/or treatment of a chronic obstructive pulmonary disease by administrating a 5-membered cyclic compound represented by the formula below: or a pharmaceutically acceptable salt of the compound or a prodrug of the compound or salt: wherein X represents an oxygen or sulfur atom; R1 represents a hydrogen atom, a substituted or unsubstituted alkyl or the like; R2 represents a hydrogen atom, a substituted or unsubstituted alkyl or the like; Y1 represents single bond, a substituted or unsubstituted alkylene or the like; the wavy line means an (E) or (Z) coordination; R3 represents a hydrogen atom, a substituted or unsubstituted aryl or the like; Y2 represents a substituted or unsubstituted alkylene or an alkenylene; R4 represents a hydrogen atom, a substituted or unsubstituted alkanoyl or the like; and R5 represents a hydrogen atom or a substituted or unsubstituted alkyl.
    • 本发明公开了一种预防和/或治疗慢性阻塞性肺疾病的方法,该方法是通过给予由下式表示的5元环状化合物:或化合物的药学上可接受的盐或其化合物或盐的前体药物:其中X 表示氧或硫原子; R1表示氢原子,取代或未取代的烷基等; R 2表示氢原子,取代或未取代的烷基等; Y1表示单键,取代或未取代的亚烷基等; 波浪线表示(E)或(Z)配位; R3表示氢原子,取代或未取代的芳基等; Y2表示取代或未取代的亚烷基或亚烯基; R4表示氢原子,取代或未取代的烷酰基等; 并且R 5表示氢原子或取代或未取代的烷基。
    • 5. 发明授权
    • Method and apparatus for error correction of stored data
    • 存储数据纠错方法和装置
    • US06587294B1
    • 2003-07-01
    • US09413011
    • 1999-10-05
    • Teruhiko UshioToshio Kanai
    • Teruhiko UshioToshio Kanai
    • G11B509
    • G11B20/1866
    • Method and apparatus to correct an error of read-out data from a data storage medium, particularly a bit shift error, is described. The correction apparatus includes a gray bit detection circuit which flags bits with a phase shift exceeding a threshold and determines whether the previous or next bit cell has a smaller phase error. An RLL error detection circuit and a table containing valid bit combinations may be used in combination with the gray bit detector to correct errors on-the-fly without degrading performance. An advantage of the invention is that it allows correction of errors without regard to conventional ECC and its maximum number of errors.
    • 描述了从数据存储介质校正读出数据的错误,特别是位移错误的方法和装置。 校正装置包括灰阶检测电路,其以相移超过阈值的位进行标识,并确定前一位或下一位单元是否具有较小的相位误差。 RLL错误检测电路和包含有效位组合的表可以与灰度位检测器组合使用,以便在不降低性能的情况下即时校正错误。 本发明的优点在于它允许校正错误,而不考虑常规ECC及其最大错误数量。
    • 10. 发明授权
    • Reproducing apparatus, recording apparatus and recording/reproducing apparatus
    • 再现装置,记录装置和记录/再现装置
    • US06292626B1
    • 2001-09-18
    • US09265700
    • 1999-03-10
    • Hidefumi InoTokuo NakataniToshio Kanai
    • Hidefumi InoTokuo NakataniToshio Kanai
    • H04N5781
    • G11B27/11G11B20/10G11B27/002G11B27/034G11B27/329G11B2020/10768G11B2220/216G11B2220/2562G11B2220/2575G11B2220/65
    • A reproducing apparatus according to the present invention includes: a first storage including a changer for housing a plurality of storage media and a drive for reading out data from first and second target storage media selected from the storage media in that order; a second storage; a data processing unit for presenting the data stored on the first and second target storage media; and a controller for controlling the changer, the drive, the data processing unit and the second storage. Before the data processing unit starts to present the data stored on the first and second target storage media, the controller controls the first storage to read out at least part of the data stored on one of the first and second target storage media as bridging data and controls the second storage to store the read bridging data. When the data processing unit starts to present the data stored on the first and second target storage media, the controller controls the second storage to supply the bridging data to the data processing unit during a period in which reading the data stored on the first and second target storage media is discontinuous because of exchange of the first target storage medium for the second target storage medium, so as to present the data stored on the first and second target storage media continuously.
    • 根据本发明的再现装置包括:第一存储器,包括用于容纳多个存储介质的更换器和用于从依次从存储介质选择的第一和第二目标存储介质读出数据的驱动器; 第二个存储; 数据处理单元,用于呈现存储在第一和第二目标存储介质上的数据; 以及用于控制更换器,驱动器,数据处理单元和第二存储器的控制器。 在数据处理单元开始呈现存储在第一和第二目标存储介质上的数据之前,控制器控制第一存储器读出存储在第一和第二目标存储介质中的一个上的数据的至少一部分作为桥接数据, 控制第二个存储以存储读桥接数据。 当数据处理单元开始呈现存储在第一和第二目标存储介质上的数据时,控制器控制第二存储器,以在其中读取存储在第一和第二目录上的数据的时段期间将桥接数据提供给数据处理单元 目标存储介质由于交换第二目标存储介质的第一目标存储介质而不连续,以便连续地呈现存储在第一和第二目标存储介质上的数据。